1. Home
  2. CBT vs CYTK Comparison

CBT vs CYTK Comparison

Compare CBT & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CBT
  • CYTK
  • Stock Information
  • Founded
  • CBT 2019
  • CYTK 1997
  • Country
  • CBT United States
  • CYTK United States
  • Employees
  • CBT N/A
  • CYTK N/A
  • Industry
  • CBT Major Chemicals
  • CYTK Biotechnology: Pharmaceutical Preparations
  • Sector
  • CBT Industrials
  • CYTK Health Care
  • Exchange
  • CBT Nasdaq
  • CYTK Nasdaq
  • Market Cap
  • CBT 6.0B
  • CYTK 6.0B
  • IPO Year
  • CBT N/A
  • CYTK 2004
  • Fundamental
  • Price
  • CBT $94.92
  • CYTK $46.36
  • Analyst Decision
  • CBT Hold
  • CYTK Buy
  • Analyst Count
  • CBT 4
  • CYTK 16
  • Target Price
  • CBT $105.00
  • CYTK $84.07
  • AVG Volume (30 Days)
  • CBT 363.2K
  • CYTK 1.1M
  • Earning Date
  • CBT 02-03-2025
  • CYTK 11-06-2024
  • Dividend Yield
  • CBT 1.77%
  • CYTK N/A
  • EPS Growth
  • CBT N/A
  • CYTK N/A
  • EPS
  • CBT 6.72
  • CYTK N/A
  • Revenue
  • CBT $3,994,000,000.00
  • CYTK $3,219,000.00
  • Revenue This Year
  • CBT $5.61
  • CYTK N/A
  • Revenue Next Year
  • CBT $3.34
  • CYTK $795.25
  • P/E Ratio
  • CBT $14.46
  • CYTK N/A
  • Revenue Growth
  • CBT 1.60
  • CYTK N/A
  • 52 Week Low
  • CBT $70.63
  • CYTK $35.66
  • 52 Week High
  • CBT $117.46
  • CYTK $110.25
  • Technical
  • Relative Strength Index (RSI)
  • CBT 26.34
  • CYTK 32.49
  • Support Level
  • CBT $103.40
  • CYTK $48.14
  • Resistance Level
  • CBT $108.93
  • CYTK $51.98
  • Average True Range (ATR)
  • CBT 3.21
  • CYTK 1.51
  • MACD
  • CBT -1.11
  • CYTK -0.32
  • Stochastic Oscillator
  • CBT 3.07
  • CYTK 5.31

About CBT Cabot Corporation

Cabot Corp manufactures and sells a variety of chemicals, materials, and chemical-based products. The company organizes itself into the following operating segments based on the product type; the Reinforcement Materials segment which generates maximum revenue provides reinforcing carbon products used in tires, and industrial products such as hoses, belts, extruded profiles, and molded goods; and the Performance Chemicals segment aggregates the specialty carbons, specialty compounds, fumed metal oxides, battery materials, inkjet colorants, and aerogel product lines. Geographically, the company derives maximum revenue from its customers in Europe, the Middle East, and Africa and the rest from the Americas and Asia Pacific region.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: